Statistics for Ikena Oncology, (id:6744 IKNA)

Valuation metrics

Market cap

81.56M

Enterprise value

-48,082,792.00

Trailing P/E (ttm)

-1.05

Forward P/E

-1.99

PEG ratio

-1.99

Price/Sales (ttm)

123.76

Price/Book (mrq)

0.61

Enterprise Value/Revenue

-72.96

Enterprise Value/EBITDA

0.76

Overview

Shares outstanding

48.26M

Float

13.87M

Shares short

129.88K

% Held by insiders

0.10%

% Held by institutions

0.64%

Average volume (10 days)

76.96K

Average volume (90 days)

Price summary

52-Week low

1.22

52-Week high

2.32

52-Week change

5.85%

Beta

0.48

50-Day moving average

1.71

200-Day moving average

1.57

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-9,755.24%

Operational effectiveness

Return on assets

-22.06%

Return on equity

-37.08%

Income statement

Revenue (ttm)

0.01

Revenue per share (ttm)

0.01

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-63,581,000.00

Net income to common (ttm)

-59,599,000.00

Diluted EPS (ttm)

-1.23

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

138.03M

Total cash per share (mrq)

2.86

Total debt (mrq)

8.39M

Total Debt/Equity (mrq)

6.25

Current ratio (mrq)

1.53K%

Book value per share (mrq)

2.78

Cash flow

Cash flow statement

-61,563,000.00

Levered free cash flow (LFCF)

-43,967,376.00